Senolytics reduce coronavirus-related mortality in old mice
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Senescent cells exacerbate COVID-19: Cellular senescence is a state elicited in response to stress signals and is associated with a damaging secretory phenotype. The number of senescent cells increases with advanced age and this in turn drives age-related diseases. Camell et al. show that senescent cells have an amplified inflammatory response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (see the Perspective by Cox and Lord). This response is communicated to nonsenescent cells, suppressing viral defense mechanisms and increasing the expression of viral entry proteins. In old mice infected with a SARS-CoV-2–related virus, treatment with senolytics to reduce the senolytic cell burden reduced mortality and increased antiviral antibodies. Science , abe4832, this issue p. eabe4832 ; see also abi4474, p. 281
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interlinked and fundamental aging processes appear to be a root-cause contributor to many disorders and diseases.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The Geroscience Hypothesis holds that these pillars of aging, including cellular senescence, tend to progress in concert and may be root-cause contributors to the pathophysiology of multiple diseases”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Persistent senescent cells appear to be highly responsive to extracellular cues, such as damage-associated molecular patterns (DAMPs) and pathogen-associated molecular patterns (PAMPs), which can exacerbate the proapoptotic, pro-inflammatory qualities of the SASP16.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SARS-CoV-2, like other viruses, can induce senescence and exacerbates the senescence-associated secretory phenotype (SASP)”
From COVID-19 and cellular senescence (2023) · cites this paper as [27]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recently, it was found that SARS-CoV-2 can evoke a form of cellular senescence, virus-induced senescence (VIS) (Box 1), through multiple mechanisms27–29”
From COVID-19 and cellular senescence (2023) · cites this paper as [27]
Experimental — accuracy not yet measured
19 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Self-citationAn Analysis of Transformations
Box, G. E. P., & Cox, D. R. (1964) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1964.tb00553.x · Cited by 15,052 · cited 1×
“05), we used zero-skewness log transformation (54).”
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664 · cited 1×
“Factors that are common components of the SASP are linked to prolonged disease, hyperinflammation/cytokine storm/acute respiratory distress syndrome (ARDS), myocarditis with troponin leak, T cell deficiencies, clotting, delirium, and multi-organ failure in SARS-CoV-2 patients (15).”
Simultaneous Statistical Inference
Miller, R. G. (1981) · Springer Series in Statistics · doi:10.1007/978-1-4613-8122-8 · Cited by 5,604
Ruan, Q., Yang, K., Wang, W., Jiang, L., & Song, J. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05991-x · Cited by 4,898 · cited 1×
“However, certain inflammatory/SASP factors released by senescent human lung cell types—including IL-1 α , IL-1 β , IL-6, MCP-1, TNF α , and MMP-1—are central to the pathological cytokine storm seen in some COVID-19 patients (4, 5, 24–33).”
Comparing Individual Means in the Analysis of Variance
Tukey, J. W. (1949) · Biometrics · doi:10.2307/3001913 · Cited by 4,246 · cited 1×
“Tukey HSD test was used for post-hoc multiple-comparison after one-or two-way ANOVA (56, 57).”
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 2×
“The generation and characterization of the INK-ATTAC transgenic mouse line has been described (42).”
Self-citationCellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225 · cited 1×
“Cellular senescence has emerged as one of the mechanisms that drives aging and age-related diseases that is most tractable to therapeutically target (6, 7).”
Self-citationCell entry mechanisms of SARS-CoV-2
Shang, J., Wan, Y., Luo, C., Ye, G., Geng, Q., Auerbach, A., & Li, F. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003138117 · Cited by 3,142
Cited by
Cellular senescence and senolytics: the path to the clinic
Chaib, S., Tchkonia, T., & Kirkland, J. L. (2022) · Nature Medicine · doi:10.1038/s41591-022-01923-y · Cited by 1,134
Self-citationSenescence and cancer — role and therapeutic opportunities
Schmitt, C. A., Wang, B., & Demaria, M. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00668-4 · Cited by 794
Cellular senescence: a key therapeutic target in aging and diseases
Zhang, L., Pitcher, L. E., Yousefzadeh, M. J., Niedernhofer, L. J., Robbins, P. D., & Zhu, Y. (2022) · Journal of Clinical Investigation · doi:10.1172/jci158450 · Cited by 631
“In addition, fisetin enhanced the immune response of old mice exposed to pathogens, including the mouse hepatitis virus, a β-coronavirus, and reduced mortality (11).”
BackgroundSelf-citationStrategies for targeting senescent cells in human disease
Gasek, N. S., Kuchel, G. A., Kirkland, J. L., & Xu, M. (2021) · Nature Aging · doi:10.1038/s43587-021-00121-8 · Cited by 501
Self-citationAging Biomarker Consortium, Bao, H., Cao, J., Chen, M., Chen, M., Chen, W., Chen, X., Chen, Y., Chen, Y., Chen, Y., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2305-0 · Cited by 376
Self-citationMechanisms and Regulation of Cellular Senescence
Roger, L., Tomas, F., & Gire, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313173 · Cited by 395
“Reducing senescent cell burden in aged mice decreases mortality after infection by a related mouse β-coronavirus [337], suggesting that cellular senescence is an important molecular mechanism of severe COVID-19.”
BackgroundSARS-CoV-2, COVID-19 and the aging immune system
Bartleson, J. M., Radenkovic, D., Covarrubias, A. J., Furman, D., Winer, D. A., & Verdin, E. (2021) · Nature Aging · doi:10.1038/s43587-021-00114-7 · Cited by 359
Virus-induced senescence is a driver and therapeutic target in COVID-19
Lee, S., Yu, Y., Trimpert, J., Benthani, F., Mairhofer, M., Richter-Pechanska, P., Wyler, E., Belenki, D., Kaltenbrunner, S., Pammer, M., et al. (2021) · Nature · doi:10.1038/s41586-021-03995-1 · Cited by 350
Interconnections between Inflammageing and Immunosenescence during Ageing
Teissier, T., Boulanger, E., & Cox, L. S. (2022) · Cells · doi:10.3390/cells11030359 · Cited by 301
“Of these, spermidine treatment, mTOR inhibition, and the selective removal of senescent cells using senolytics are most strongly supported by model organism studies and human clinical trial data, with significant scope for immune benefit even against severe infections, such as that caused by SARS-CoV-2.”
BackgroundInfluentialCytoplasmic DNA: sources, sensing, and role in aging and disease
Miller, K. N., Victorelli, S. G., Salmonowicz, H., Dasgupta, N., Liu, T., Passos, J. F., & Adams, P. D. (2021) · Cell · doi:10.1016/j.cell.2021.09.034 · Cited by 288
Immune Senescence, Immunosenescence and Aging
Lee, K.-A., Flores, R. R., Jang, I. H., Saathoff, A., & Robbins, P. D. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.900028 · Cited by 283
“An increase of MCP-1, a SASP factor, is associated with mortality in COVID-19 infection and the genetic or pharmacological clearance of senescent cells from aged mice improved the survival against ß-coronavirus infection (Abers et al., 2021; Camell et al., 2021).”
BackgroundInfluentialSelf-citationAdverse effects of COVID-19 mRNA vaccines: the spike hypothesis
Trougakos, I. P., Terpos, E., Alexopoulos, H., Politou, M., Paraskevis, D., Scorilas, A., Kastritis, E., Andreakos, E., & Dimopoulos, M. A. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.04.007 · Cited by 273
“These proinflammatory effects could be particularly pronounced in the elderly, since recent data revealed that senescent cells become hyperinflammatory in response to the S1 subunit, followed by increased expression of viral entry proteins and reduced antiviral gene expression in nonsenescent cells through a paracrine…”
A single-cell transcriptomic landscape of the lungs of patients with COVID-19
Wang, S., Yao, X., Ma, S., Ping, Y., Fan, Y., Sun, S., He, Z., Shi, Y., Sun, L., Xiao, S., et al. (2021) · Nature Cell Biology · doi:10.1038/s41556-021-00796-6 · Cited by 199
Gyöngyösi, M., Alcaide, P., Asselbergs, F. W., Brundel, B. J. J. M., Camici, G. G., Martins, P. D. C., Ferdinandy, P., Fontana, M., Girao, H., Gnecchi, M., et al. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvac115 · Cited by 164
Why Senescent Cells Are Resistant to Apoptosis: An Insight for Senolytic Development
Hu, L., Li, H., Zi, M., Li, W., Liu, J., Yang, Y., Zhou, D., Kong, Q.-P., Zhang, Y., & He, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.822816 · Cited by 160
“, 2021) and perhaps other viral infections (Camell et al., 2021).”
BackgroundAging and chronic inflammation: highlights from a multidisciplinary workshop
Saavedra, D., Añé-Kourí, A. L., Barzilai, N., Caruso, C., Cho, K., Fontana, L., Franceschi, C., Frasca, D., Ledón, N., Niedernhofer, L. J., et al. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00352-w · Cited by 167
Self-citationThe Role of Epithelial Damage in the Pulmonary Immune Response
Burgoyne, R. A., Fisher, A. J., & Borthwick, L. A. (2021) · Cells · doi:10.3390/cells10102763 · Cited by 165
“demonstrated that senescent cells increase the inflammatory response to β-coronavirus mouse hepatitis virus (MHV) infection (a virus in the same family as SARSCoV-2) in aged mouse models and that treatment with the senolytic compound fisetin could reduce adverse outcomes and increase levels of antiviral antibodies [24…”
BackgroundCOVID-19 and cellular senescence
Schmitt, C. A., Tchkonia, T., Niedernhofer, L. J., Robbins, P. D., Kirkland, J. L., & Lee, S. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00785-2 · Cited by 153
Self-citationStress, epigenetics, and aging: Unraveling the intricate crosstalk
Wu, Z., Qu, J., Zhang, W., & Liu, G.-H. (2024) · Molecular Cell · doi:10.1016/j.molcel.2023.10.006 · Cited by 134
New Dawn for Atherosclerosis: Vascular Endothelial Cell Senescence and Death
Bu, L.-L., Yuan, H., Xie, L., Guo, M.-H., Liao, D., & Zheng, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015160 · Cited by 145
Dinnon, K. H., Leist, S. R., Okuda, K., Dang, H., Fritch, E. J., Gully, K. L., la Cruz, G. D., Evangelista, M. D., Asakura, T., Gilmore, R. C., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abo5070 · Cited by 149
The costs and benefits of senotherapeutics for human health
Raffaele, M., & Vinciguerra, M. (2022) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(21)00300-7 · Cited by 140
Lelarge, V., Capelle, R., Oger, F., Mathieu, T., & Le Calvé, B. (2024) · npj Aging · doi:10.1038/s41514-024-00138-4 · Cited by 140
“More recently, Fisetin treatment in SARS-CoV-2 infection displayed a signi fi cant activity in vivo by eliminating senescent cells and reduced mortality associated with the virus 22 .”
BackgroundFlavonoids—Natural Gifts to Promote Health and Longevity
Fan, X., Fan, Z., Yang, Z., Huang, T., Tong, Y., Yang, D., Mao, X., & Yang, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042176 · Cited by 140
“Notably, fisetin treatment significantly reduced mortality, cellular senescence, and inflammatory markers and increased antiviral antibodies when the SARS-CoV-2-related mouse β-coronavirus was exposed to old mouse pathogens [78].”
BackgroundMitochondrial dysfunction and its association with age-related disorders
Somasundaram, I., Jain, S. M., Blot‐Chabaud, M., Pathak, S., Banerjee, A., Rawat, S. J., Sharma, N. R., & Duttaroy, A. K. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1384966 · Cited by 138
Cellular senescence: Neither irreversible nor reversible
Reimann, M., Lee, S., & Schmitt, C. A. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20232136 · Cited by 134
“This has been recently demonstrated for severe COVID-19 (Camell et al., 2021; D ’ Agnillo et al., 2021; Evangelou et al., 2022; Lee et al., 2021; Tsuji et al., 2022; Wang et al., 2021).”
BackgroundSenNet Consortium, Writing Group, Lee, P. J., Benz, C. C., Blood, P., Börner, K., Campisi, J., Chen, F., Daldrup-Link, H., De Jager, P., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00326-5 · Cited by 122
“Indeed, preexisting SnCs impair host responses to tissue injury or infection 5 , thereby promoting disease in a feed-forward mechanism.”
BackgroundSelf-citationSenescent Cells: A Therapeutic Target in Cardiovascular Diseases
Suda, M., Paul, K. H., Minamino, T., Miller, J. D., Lerman, A., Ellison-Hughes, G. M., Tchkonia, T., & Kirkland, J. L. (2023) · Cells · doi:10.3390/cells12091296 · Cited by 112
“Advanced biological age is also associated with loss of physical resilience, such as against infection [199,200], injury, or surgery or dampened vaccination responses.”
BackgroundSelf-citationKandhaya‐Pillai, R., Yang, X., Tchkonia, T., Martin, G. M., Kirkland, J. L., & Oshima, J. (2022) · Aging Cell · doi:10.1111/acel.13646 · Cited by 119
“Recently, we reported that senolytic drugs reduce inflammation, senescent cell burden, and complications from infection of older mice by a β- coronavirus, mouse hepatitis virus, which is related to SARS- CoV- 2 (Camell et al., 2021).”
BackgroundInfluentialSelf-citationThe 3 I’s of immunity and aging: immunosenescence, inflammaging, and immune resilience
Wrona, M. V., Ghosh, R. B., Coll, K., Chun, C., & Yousefzadeh, M. J. (2024) · Frontiers in Aging · doi:10.3389/fragi.2024.1490302 · Cited by 123
Self-citationStrategies for late phase preclinical and early clinical trials of senolytics
Wissler Gerdes, E. O., Misra, A., Netto, J. M. E., Tchkonia, T., & Kirkland, J. L. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111591 · Cited by 103
Self-citationKrzystyniak, A., Wesierska, M., Petrazzo, G., Gadecka, A., Dudkowska, M., Bielak-Zmijewska, A., Mosieniak, G., Figiel, I., Wlodarczyk, J., & Sikora, E. (2022) · Aging · doi:10.18632/aging.203835 · Cited by 105
“The decreasing burden of senescent cells has been shown to reduce peripheral inflammation [27].”
BackgroundTargeting senescent cells for a healthier longevity: the roadmap for an era of global aging
Sun, Y., Li, Q., & Kirkland, J. L. (2022) · Life Medicine · doi:10.1093/lifemedi/lnac030 · Cited by 105
Self-citationFisetin as a senotherapeutic agent: Evidence and perspectives for age-related diseases
Tavenier, J., Nehlin, J. O., Houlind, M. B., Rasmussen, L. J., Tchkonia, T., Kirkland, J. L., Andersen, O., & Rasmussen, L. J. H. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111995 · Cited by 111
“Accumulating evidence suggests that aging and many chronic diseases share common biological pathways, including chronic inflammation and cellular senescence (Ferrucci and Fabbri, 2018; Franceschi et al., 2018; Furman et al., 2019; Tchkonia et al., 2021).”
Self-citationTripathi, U., Misra, A., Tchkonia, T., & Kirkland, J. L. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111548 · Cited by 104
“…osteoarthritis), inflammatory cytokines (e.g., TNF α )[33], damage-associated molecular patterns (DAMPs, e.g., released intracellular contents signaling breakage of neighboring cells), and pathogen associated molecular patterns (PAMPs; e.g., bacterial endotoxins or components of viruses) [18, 22].”
Self-citationEvangelou, K., Veroutis, D., Paschalaki, K., Foukas, P. G., Lagopati, N., Dimitriou, M., Papaspyropoulos, A., Konda, B., Hazapis, O., Polyzou, A., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.02951-2021 · Cited by 98
The CD38 glycohydrolase and the NAD sink: implications for pathological conditions
Zeidler, J. D., Hogan, K. A., Agorrody, G., Peclat, T., Kashyap, S., Kanamori, K. S., Gomez, L. S., Mazdeh, D. Z., Warner, G. M., Thompson, K. L., et al. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00451.2021 · Cited by 96
Tripathi, U., Nchioua, R., Prata, L. G. P. L., Zhu, Y., Gerdes, E. O. W., Giorgadze, N., Pirtskhalava, T., Parker, E., Xue, A., Espindola-Netto, J. M., et al. (2021) · Aging · doi:10.18632/aging.203560 · Cited by 88
“However, it has only recently become apparent that the SASP can be amplified www.aging-us.com 21845 AGING by signals like PAMPs, such as lipopolysaccharide or S1 antigen, as predicted by our SASP “Amplifier/ Rheostat Hypothesis” [3].”
InfluentialSelf-citationTsuji, S., Minami, S., Hashimoto, R., Konishi, Y., Suzuki, T., Kondo, T., Sasai, M., Torii, S., Ono, C., Shichinohe, S., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00170-7 · Cited by 84
Cellular senescence and the host immune system in aging and age-related disorders
Giannoula, Y., Kroemer, G., & Pietrocola, F. (2023) · Biomedical Journal · doi:10.1016/j.bj.2023.02.001 · Cited by 79
“Healthpromoting effects associated with the clearance of senescent cells in vivo were also described for glutaminolysis inhibitors [44], cardiac glycosides [45] and fisetin [41,46].”
BackgroundSanborn, M. A., Wang, X., Gao, S., Dai, Y., & Rehman, J. (2025) · Nature Communications · doi:10.1038/s41467-025-57047-7 · Cited by 82
“The senescent cell burdeninagedorganismsalsocontributestouncheckedin fl ammation and poor outcomes in acute diseases, such as coronavirus infection 9 .”
Senolytic therapy alleviates physiological human brain aging and COVID-19 neuropathology
Aguado, J., Amarilla, A. A., Taherian Fard, A., Albornoz, E. A., Tyshkovskiy, A., Schwabenland, M., Chaggar, H. K., Modhiran, N., Gómez-Inclán, C., Javed, I., et al. (2023) · Nature Aging · doi:10.1038/s43587-023-00519-6 · Cited by 80
“This is consistent with preclinical studies demonstrating a beneficial effect of senescent cell clearance in reducing inflammatory/SASP gene expression in the brains of geriatric mice infected with a SARS-CoV-2-related mouse β-coronavirus 54 .”
Targeting cellular senescence in metabolic disease
Palmer, A. K., Tchkonia, T., & Kirkland, J. L. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101601 · Cited by 79
Self-citationAbdelgawad, I. Y., Agostinucci, K. J., Sadaf, B., Grant, M. K. O., & Zordoky, B. N. M. (2023) · Frontiers in Aging · doi:10.3389/fragi.2023.1170434 · Cited by 76
“Recently, senolytics were demonstrated to decrease the mortality of aged mice exposed to a mouse β-coronavirus, further supporting the detrimental role of senescence in infections (Camell et al., 2021).”
BackgroundInfluentialRole of Senescence and Aging in SARS-CoV-2 Infection and COVID-19 Disease
Lynch, S. M., Guo, G., Gibson, D. S., Bjourson, A. J., & Singh, T. (2021) · Cells · doi:10.3390/cells10123367 · Cited by 75
Immunosenescence and inflamm-ageing in COVID-19
Zinatizadeh, M. R., Zarandi, P. K., Ghiasi, M., Kooshki, H., Mohammadi, M., Amani, J., & Rezaei, N. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101818 · Cited by 77
“C motif chemokine ligand; NOD, Nucleotide-binding oligomerization domain; NLRs, NOD-like receptors; NLRP3, NLRs-pyrin domain-containing protein 3; DAMPs, Damage-associated molecular patterns; ROS, Reactive oxygen species; ATP, Adenosine triphosphate; TLR, Toll-like receptor; SASP, Senescence-associated secretory pheno…”
Effect of peripheral cellular senescence on brain aging and cognitive decline
Budamagunta, V., Kumar, A., Rani, A., Bean, L. A., Manohar‐Sindhu, S., Yang, Y., Zhou, D., & Foster, T. C. (2023) · Aging Cell · doi:10.1111/acel.13817 · Cited by 76
“In addition to decreasing basal measures of systemic inflammation, senolytic treatment can inhibit the hyper- responsive release of SASP factors during acute systemic inflammation (Budamagunta, Manohar- Sindhu, et al., 2021; Camell et al., 2021).”
BackgroundCellular Senescence in Aging Lungs and Diseases
Aghali, A., Ngassie, M. L. K., Pabelick, C. M., & Prakash, Y. S. (2022) · Cells · doi:10.3390/cells11111781 · Cited by 69
Self-citationImmunosenescence in atherosclerosis: A role for chronic viral infections
Talepoor, A. G., & Doroudchi, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.945016 · Cited by 71
Exercise Counters the Age-Related Accumulation of Senescent Cells
Zhang, X., Englund, D. A., Aversa, Z., Jachim, S. K., White, T. A., & LeBrasseur, N. K. (2022) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000302 · Cited by 63
“Senescent cells are a plausible contributor to age-associated inflammation, as the SASP is a veritable source of proinflammatory cytokines and chemokines that recruit, anchor, and amplify the activities of immune cells (27).”
BackgroundSelf-citationLv, N., Zhao, Y., Liu, X., Ye, L., Liang, Z., Kang, Y., Dong, Y., Wang, W., Kolliputi, N., & Shi, L. (2022) · Aging Cell · doi:10.1111/acel.13594 · Cited by 64
“Telomeres are repetitive DNA sequences occupying at the ends of chromosomes and play an essential role in maintaining genomic integrity and stability (Chakravarti et al., 2021).”
BackgroundKempuraj, D., Aenlle, K. K., Cohen, J., Mathew, A., Isler, D., Pangeni, R. P., Nathanson, L., Theoharides, T. C., & Klimas, N. G. (2023) · The Neuroscientist · doi:10.1177/10738584231194927 · Cited by 67
“These results indicate that reducing senescent cells could reduce mortality with SARS-CoV-2 infection (Camell and others 2021; Schmitt and others 2023).”
Matsumoto, C., Shibata, S., Kishi, T., Morimoto, S., Mogi, M., Yamamoto, K. I., Kobayashi, K., Tanaka, M., Asayama, K., Yamamoto, E., et al. (2022) · Hypertension Research · doi:10.1038/s41440-022-01145-2 · Cited by 63
“In fact, the beneficial effect of senolytics, such as fisetin and senolytic cocktail, Dasatinib plus Quercetin contribute to improved outcomes in old mice exposed to viruspathogen [123].”
BackgroundIltis, C., Moskalevska, I., Debiesse, A., Seguin, L., Fissoun, C., Cervera, L., Moudombi, L., Ardin, M., Ferrari, A., Eliott, C., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00776-z · Cited by 59
Extending human healthspan and longevity: a symposium report
DeVito, L. M., Barzilai, N., Cuervo, A. M., Niedernhofer, L. J., Milman, S., Levine, M. E., Promislow, D., Ferrucci, L., Kuchel, G. A., Mannick, J. B., et al. (2021) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14681 · Cited by 61
Self-citationDelval, L., Hantute-Ghesquier, A., Sencio, V., Flaman, J., Robil, C., Angulo, F. S., Lipskaia, L., Çobanoglu, Ö., Lacoste, A., Machelart, A., et al. (2023) · Nature Aging · doi:10.1038/s43587-023-00442-w · Cited by 60
“Camell et al.(31) recently investigated the role of age-dependent, preexisting senescent cells during an infection with a hepatotropic and neurotropic betacoronavirus (mouse hepatitis virus) in aged mice.”
BackgroundResultInfluentialCalabrò, A., Accardi, G., Aiello, A., Caruso, C., Galimberti, D., & Candore, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031792 · Cited by 53
“The use of senotherapeutic agents has been developing in the last years thanks to their action in the efficiency of transplantation in animal models and humans and the reduction in mortality in aged mice models infected with SARS-CoV-2 [54].”
BackgroundInfluentialLipopolysaccharides and Cellular Senescence: Involvement in Atherosclerosis
Suzuki, K., Susaki, E. A., & Nagaoka, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911148 · Cited by 56
“LPS from Campylobacter rectus, a sociated with adult periodontitis, induced the higher production of IL-6 and plasminogen activator in senesce t gingival fibroblasts repared by serial passage [99,100], while LPS increased the expression of IL-1α, IL-1β, IL-6, MCP-1, and PAI-2 in senescent adipocyte progenitors prepare…”
BackgroundThe way of SARS-CoV-2 vaccine development: success and challenges
Dong, Y., Dai, T., Wang, B., Zhang, L., Zeng, L., Huang, J., Yan, H., Zhang, L., & Zhou, F. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00796-w · Cited by 58
Self-citationLiu, L., Yue, X., Sun, Z., Hambright, W. S., Feng, Q., Cui, Y., Huard, J., Robbins, P. D., Wang, Z., & Mu, X. (2022) · Aging · doi:10.18632/aging.204275 · Cited by 49
Self-citationApostolou, E., Rizwan, M., Moustardas, P., Sjøgren, P., Bertilson, B. C., Bragée, B., Polo, O. J., & Rosén, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.949787 · Cited by 56
“This is consistent with the hypothesis of a hyperinflammatory response to pathogen-associated molecular patterns (PAMPs), including SARS-CoV-2 spike protein-1, in patients with multiple chronic diseases (32).”
BackgroundResultEmerging rejuvenation strategies—Reducing the biological age
Zhang, B., Trapp, A., Kerepesi, C., & Gladyshev, V. N. (2022) · Aging Cell · doi:10.1111/acel.13538 · Cited by 51
“…blood components Low DNAm age (a) (b) Differential damage clearance High biological age Low biological age and cardiovascular systems, and reduce the age- related mortality pertinent to coronavirus in mouse models (Camell et al., 2021; Gasek et al., 2021; Xu et al., 2018; Zhu et al., 2015).”
BackgroundLiu, L., Yue, X., Sun, Z., Hambright, W. S., Wei, J., Li, Y., Matre, P. R., Cui, Y., Wang, Z., Rodney, G. G., et al. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13101 · Cited by 53
Self-citationForsyth, C. B., Zhang, L., Bhushan, A., Swanson, B. A., Zhang, L., Mamede, J. I., Voigt, R. M., Shaikh, M. W., Engen, P. A., & Keshavarzian, A. (2022) · Microorganisms · doi:10.3390/microorganisms10101996 · Cited by 52
Self-citationFisetin for COVID ‐19 in skilled nursing facilities: Senolytic trials in the COVID era
Verdoorn, B. P., Evans, T. K., Hanson, G. J., Zhu, Y., Langhi Prata, L. G. P., Pignolo, R. J., Atkinson, E. J., Wissler‐Gerdes, E. O., Kuchel, G. A., Mannick, J. B., et al. (2021) · Journal of the American Geriatrics Society · doi:10.1111/jgs.17416 · Cited by 50
Self-citationImplications of Innate Immunity in Post-Acute Sequelae of Non-Persistent Viral Infections
Hirschenberger, M., Hunszinger, V., & Sparrer, K. M. J. (2021) · Cells · doi:10.3390/cells10082134 · Cited by 60
Richardson, M., & Richardson, D. R. (2023) · Molecular Pharmacology · doi:10.1124/molpharm.123.000803 · Cited by 50
Clonal dynamics and somatic evolution of haematopoiesis in mouse
Kapadia, C. D., Williams, N., Dawson, K. J., Watson, C. J., Yousefzadeh, M. J., Le, D. T., Nyamondo, K., Kodavali, S., Cagan, A., Waldvogel, S. M., et al. (2025) · Nature · doi:10.1038/s41586-025-08625-8 · Cited by 51
Self-citationMazan-Mamczarz, K., Tsitsipatis, D., Childs, B. G., Carr, A. E., Dos Santos, C. R., Anerillas, C., Romero, B., Gregg, J. M., Henry-Smith, C., Okereke, A. N., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00889-z · Cited by 48
“Although the efficacy of these drugs has been shown in animal models, no disease-modifying senotherapeutic drug has successfully passed human clinical trials yet 42–44 .”
Lorenzo, E. C., Torrance, B. L., Keilich, S. R., Al‐Naggar, I. M., Harrison, A. G., Xu, M., Bartley, J. M., & Haynes, L. (2021) · Aging Cell · doi:10.1111/acel.13525 · Cited by 50
Ijima, S., Saito, Y., Nagaoka, K., Yamamoto, S., Sato, T., Miura, N., Iwamoto, T., Miyajima, M., & Chikenji, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.960601 · Cited by 50
The central role of DNA damage in immunosenescence
Kell, L., Simon, A. K., Alsaleh, G., & Cox, L. S. (2023) · Frontiers in Aging · doi:10.3389/fragi.2023.1202152 · Cited by 47
“Importantly, removing senescent cells improved the survival of mice after beta-coronavirus infection, indicating the core role of VIS in the pathology of viral infection (Camell et al., 2021; Cox and Lord, 2021).”
BackgroundInfluentialHan, J. J. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.09.007 · Cited by 49
Enhancing immunity during ageing by targeting interactions within the tissue environment
Bracken, O. V., Maeyer, R. P. H. D., & Akbar, A. N. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01126-9 · Cited by 45
“These drugs might be particularly relevant for the treatment of COVID-19 in the elderly, because two studies in old mice showed that administration of D + Q or fisetin reduced mortality associated with a coronavirus infection 121,122 .”
Plasma Proteomics of COVID-19–Associated Cardiovascular Complications
Roh, J. D., Kitchen, R. R., Guseh, J. S., McNeill, J. N., Aïd, M., Martinot, A. J., Yu, A., Platt, C., Rhee, J., Weber, B., et al. (2022) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2022.01.013 · Cited by 53
“Hyperlipidemia 11 (42) 8 (62) 7 (58) 7 (50) 9 (60) 0.”
Urata, R., Ikeda, K., Yamazaki, E., Ueno, D., Katayama, A., Shin‐Ya, M., Ohgitani, E., Mazda, O., & Matoba, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-15976-z · Cited by 43
Effects of Fisetin Treatment on Cellular Senescence of Various Tissues and Organs of Old Sheep
Huard, C., Gao, X., Hazra, M. E. D., Hazra, R.-O. D., Lebsock, K., Easley, J. T., Millett, P. J., & Huard, J. (2023) · Antioxidants · doi:10.3390/antiox12081646 · Cited by 41
Death-seq identifies regulators of cell death and senolytic therapies
Colville, A., Liu, J., Rodríguez-Mateo, C., Thomas, S. M., Ishak, H. D., Zhou, R., Klein, J. D. D., Morgens, D. W., Goshayeshi, A., Salvi, J. S., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.08.008 · Cited by 42
The ageing immune system as a driver of systemic ageing
Jang, I. H., Niedernhofer, L. J., Robbins, P. D., & Camell, C. D. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-026-01269-3 · Cited by 45
“Given that immune cells can develop a senescent-like phenotype, it is not surprising that treatment with seno-therapeutics improves immune function and extends healthspan 4,177 .”
Self-citationTargeting senescent cells for the treatment of age-associated diseases
Suda, M., Tchkonia, T., Kirkland, J. L., & Minamino, T. (2024) · The Journal of Biochemistry · doi:10.1093/jb/mvae091 · Cited by 39
Self-citationCellular Senescence in Immunity against Infections
Marrella, V., Facoetti, A., & Cassani, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911845 · Cited by 44
“Of note, the excessive generation of the SASP can also contribute to hyperinflammation (cytokine storm) associated pathogenic responses to stimuli [8].”
BackgroundCell Survival, Death, and Proliferation in Senescent and Cancer Cells: the Role of (Poly)phenols
Sorrenti, V., Buriani, A., Fortinguerra, S., Davinelli, S., Scapagnini, G., Cassidy, A., & Vivo, I. D. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.05.014 · Cited by 39
“Clinical trials are underway to validate these promising results [251].”
BackgroundRole of senescence in the chronic health consequences of COVID-19
Wissler Gerdes, E. O., Vanichkachorn, G., Verdoorn, B. P., Hanson, G. J., Joshi, A. Y., Murad, M. H., Rizza, S. A., Hurt, R. T., Tchkonia, T., & Kirkland, J. L. (2022) · Translational Research · doi:10.1016/j.trsl.2021.10.003 · Cited by 38
“Pang L, Liu Y, Shen M, et al. Influence of aging on deteriora- tion of patients with COVID-19.”
InfluentialSelf-citationCOVID-19 Immunobiology: Lessons Learned, New Questions Arise
Kaklamanos, A., Belogiannis, K., Skendros, P., Gorgoulis, V. G., Vlachoyiannopoulos, P. G., & Tzioufas, A. G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.719023 · Cited by 41
“In the light of findings pinpointing cellular senescence as an important disease modulator, especially in high-risk populations (31, 237, 238), such efforts could be expanded to include experimental use of senolytic drugs as well.”
BackgroundBranched‐Chain Amino Acid Accumulation Fuels the Senescence‐Associated Secretory Phenotype
Liang, Y., Pan, C. C., Yin, T., Wang, L., Gao, X., Wang, E., Quang, H., Huang, D., Tan, L., Xiang, K., et al. (2023) · Advanced Science · doi:10.1002/advs.202303489 · Cited by 44
Samsudin, F., Raghuvamsi, P. V., Petruk, G., Puthia, M., Petrlová, J., MacAry, P. A., Anand, G. S., Bond, P. J., & Schmidtchen, A. (2022) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjac058 · Cited by 39
“exchange values at labelling times 1 and 10 min for S protein domains NTD (i), RBD (ii) and S2 domain (iii) are mapped on to the respective structures (C) Differences in deuterium exchange values at labelling times t= 1 min and 10 min are mapped on to the full-length S protein (14-1208) structure.”
BackgroundPast and Future Directions for Research on Cellular Senescence
Zhu, Y. Z., Anastasiadis, Z. P., Espíndola‐Netto, J. M., Evans, T. S., Tchkonia, T., & Kirkland, J. L. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041205 · Cited by 39
Self-citationMetabolic remodeling in cancer and senescence and its therapeutic implications
Kim, Y., Jang, Y., Kim, M.-S., & Kang, C. (2024) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2024.02.008 · Cited by 36
Immune aging and infectious diseases
Chen, R., Zou, J., Chen, J., Wang, L., Kang, R., & Tang, D. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003410 · Cited by 39
“[ 357 , 358 ] Currently, human clinical trials are underway for the senolytic agent fisetin for prophylaxis and treatment of COVID-19 in older patients with mild to severe cases (ClinicalTrials.gov: NCT04537299, NCT04476953).”
The secretome of senescent monocytes predicts age-related clinical outcomes in humans
Olinger, B., Banarjee, R., Dey, A. K., Tsitsipatis, D., Tanaka, T., Ram, A., Nyunt, T., Daya, G. N., Peng, Z., Shrivastava, M., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00877-3 · Cited by 37
Zhao, J., Zheng, L., Dai, G., Sun, Y. E., He, R., Liu, Z., Jin, Y., Wu, T., Hu, J., Cao, Y. B., et al. (2024) · The Spine Journal · doi:10.1016/j.spinee.2024.09.017 · Cited by 36
Targeting the hallmarks of aging to improve influenza vaccine responses in older adults
Cadar, A. N., Martin, D. E., & Bartley, J. M. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00348-6 · Cited by 35
“To date, senolytics have been shown to alleviate senescence-induced changes in CD4 T helper (Th) subset differentiation in the context of flu infection [39] and reduce coronavirus induced-mortality in aged mice [107].”
BackgroundA nutrigeroscience approach: Dietary macronutrients and cellular senescence
Calubag, M. F., Robbins, P. D., & Lamming, D. W. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.07.025 · Cited by 35
Self-citationAnti-senescence therapies: a new concept to address cardiovascular disease
Stojanović, S. D., Thum, T., & Bauersachs, J. K. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf030 · Cited by 34
“145 A presumed mechanism of action for fisetin is senolysis through the inhibition of the BCL-2/BCL-xl/ BCL-w survival network.”
The Role of Cellular Senescence in Cyclophosphamide-Induced Primary Ovarian Insufficiency
Xu, Z., Takahashi, N., Harada, M., Kunitomi, C., Kusamoto, A., Koike, H., Tanaka, T., Sakaguchi, N., Urata, Y., Wada‐Hiraike, O., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417193 · Cited by 33
“Senolytics are new and promising therapeutic agents, not only for aging-related diseases but also for various inflammation-related diseases, such as osteoarthritis and COVID-19 [25,26].”
BackgroundRevolutionizing Diabetic Foot Ulcer Care: The Senotherapeutic Approach
Zhang, G., Samarawickrama, P. N., Gui, L., Ma, Y., Cao, M., Zhu, H., Li, W., Yang, H., Li, K., Yang, Y., et al. (2024) · Aging and Disease · doi:10.14336/ad.2024.0065 · Cited by 32
“They have been found to mitigate COVID-19-reminiscent lung disease and reduce mortality rates in mice [142, 143].”
Optimising vaccine immunogenicity in ageing populations: key strategies
Jiang, G., Zou, Y., Zhao, D., & Yu, J. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(24)00497-3 · Cited by 34
Sahu, P., & Satapathy, T. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01867-y · Cited by 35
Pawar, A. T., Russo, M., Rani, I., Goswami, K., Russo, G. L., & Pal, A. (2022) · Phytotherapy Research · doi:10.1002/ptr.7461 · Cited by 30
Retuerto, M., Lledó, A., Fernández-Varas, B., Guerrero, R., Usategui, A., Lalueza, A., García-García, R., Mancebo, E., Paz‐Artal, E., Sastre, L., et al. (2022) · Immunity & Ageing · doi:10.1186/s12979-022-00294-9 · Cited by 30
“Virus induced cell senescence has also been shown to significantly contribute to COVID-19 pathology which can be attenuated by senolytics in experimental models [10, 11].”
Background
Metadata
- Authors
- Camell, C. D., Yousefzadeh, M. J., Zhu, Y., Prata, L. G. P. L., Huggins, M. A., Pierson, M., Zhang, L., O’Kelly, R. D., Pirtskhalava, T., Xun, P., Ejima, K., Xue, A., Tripathi, U., Espindola-Netto, J. M., Giorgadze, N., Atkinson, E. J., Inman, C. L., Johnson, K. O., Cholensky, S. H., Carlson, T. W., LeBrasseur, N. K., Khosla, S., O’Sullivan, M. G., Allison, D. B., Jameson, S. C., Meves, A., Li, M., Prakash, Y. S., Chiarella, S. E., Hamilton, S. E., Tchkonia, T., Niedernhofer, L. J., Kirkland, J. L., & Robbins, P. D.
- Affiliations
- University of Minnesota (US)
- Mayo Clinic (US)
- Institute on the Biology of Aging and Metabolism, Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA.
- Indiana University Bloomington (US)
- Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.
- Corresponding author
- Camell, Christina D.
- Yousefzadeh, Matthew J.
- Zhu, Yi
- Prata, Larissa G. P. Langhi
- Hamilton, Sara E.
- Niedernhofer, Laura J.
- Kirkland, James L.
- Robbins, Paul D.
- ORCID
- Camell, Christina D.
- Yousefzadeh, Matthew J.
- Zhu, Yi
- Prata, Larissa G. P. Langhi
- Huggins, Matthew A.
- Pierson, Mark
- Zhang, Lei
- Pirtskhalava, Tamar
- Xun, Pengcheng
- Ejima, Keisuke
- Tripathi, Utkarsh
- Atkinson, Elizabeth J.
- Johnson, Kurt O.
- Carlson, Timothy W.
- LeBrasseur, Nathan K.
- Khosla, Sundeep
- O’Sullivan, M. Gerard
- Allison, David B.
- Jameson, Stephen C.
- Meves, Alexander
- Li, Ming
- Prakash, Y. S.
- Chiarella, Sergio E.
- Hamilton, Sara E.
- Tchkonia, Tamara
- Niedernhofer, Laura J.
- Kirkland, James L.
- Robbins, Paul D.
- Venue
- Science
- Published
- 2021-07-16
- Volume
- 373
- Issue
- 6552
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC8607935
- OpenAlex
- W3172838821
- Cited by
- 320
- References
- 59
- Citations by year
- 2026: 32 · 2025: 51 · 2024: 55 · 2023: 57 · 2022: 81 · 2021: 44
- FWCI
- 37.23
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Science (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG063543-02S1, AG043376, AG056278, AG063543, AG062413, AG013925, AG058800)
- University of Minnesota Clinical and Translational Science Institute (N/A)
- Connor Fund (N/A)
- Robert J. and Theresa W. Ryan Fund (N/A)
- Noaber Foundation (N/A)
- Glenn Foundation for Medical Research (N/A)
- American Federation for Aging Research (N/A)
- American Foundation for Aging Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Keywords
- senolytics, cellular senescence, SARS-CoV-2, COVID-19 mortality, aging, inflammation, pathogen-associated molecular patterns, spike protein, antiviral gene expression, paracrine signaling, antiviral antibodies, age-related diseases
- MeSH terms
- Dasatinib, Pathogen-Associated Molecular Pattern Molecules, Receptors, Coronavirus, COVID-19, COVID-19 Drug Treatment, Aging, Animals, Cell Line, Female, Gene Expression Regulation, Murine hepatitis virus, Humans, Lipopolysaccharides, Male, Mice, Inbred C57BL, Quercetin, Specific Pathogen-Free Organisms, Cellular Senescence, Coronavirus Infections, Flavonols, Mice, Spike Glycoprotein, Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.